Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

News

MSU starts student-run VC fund
MSU’s Student Venture Capital Fund will invest up to $50,000 in university-linked businesses with the administrative aid of MSU students taking the entrepreneurial finance course.
Deciphex decodes $2.6m
Based at DCU Invent, Deciphex has gained investors including Inova and GI Partners as it looks to refine its offering for the toxicologic and gastrointestinal segments of pathology.
Michigan marks Applied Morphomics
Applied Morphomics has formally spun out of University of Michigan to deliver a medical analytics service powered by morphological scans of patients.
IIT-D prepares deep tech strategy
Indian Institute of Technology-Delhi will launch a deep tech incubator and innovation strategy on the back of its recent success in becoming an Indian government-sponsored institute of eminence.
Oxford Brain Diagnostics secures funding
Oxford Brain Diagnostics hopes to commercialise an early diagnosis tool for Alzheimer’s disease pioneered through eight years of University of Oxford research.
Mind Foundry discerns Parkwalk funding
The follow-on investment complements $1.7m raised by Oxford data analytics spinout Mind Foundry in 2016 from investors including Oxford Sciences Innovation.
Think-Lands needles $3m
Building on Chiba and Hokkaido university research, Think-Lands is aiming to commercialise microneedles manufactured with its optical vortex production system.
Oxford spinouts score $61m in first quarter
The total raised by Oxford’s spinouts was down from $229m year-on-year, though university tech transfer office OUI also marked its largest ever single exit during the period.

News Continued

Talaris takes home $100m series A
Talaris, previously known as Regenerex and based on research at University of Louisville, will use the funding to advance its cell therapy into later-stage clinical development.
Arrakis arranges $75m series B
Osage University has returned for a $75m series B round raised by Arrakis Therapeutics, which has licensed technology from University of Pennsylvania.
Christou departs CIC
Victor Christou has stepped down from his position as chief executive of Cambridge Innovation Capital just weeks after helping the unit raise $196m in additional funding.
Morley continues to make his mark on Pitt
Scott Morley has been appointed as director of the [email protected] medtech accelerator, in addition to his duties as entrepreneur-in-residence at the university's Innovation Institute.
Marshall University unveils incubator
The Brad D Smith Incubator is a partnership between the university’s Brad D Smith Schools of Business and Robert C Byrd Institute, and will welcome tenants this summer.
Gen.G generates $46m round
Stanford University has participated in a $46m funding round for Gen.G together with venture capital firms and celebrity investors such as actor Will Smith.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
test reg

Login